In a patient with an HR-proficient stage III high-grade serous ovarian cancer s/p R0 primary debulking surgery for whom you are not considering bevacizumab in addition to chemotherapy, would you consider IP chemotherapy?
Why or why not?
For what patient population(s), if any, are you recommending IP chemotherapy?
Community PollStarted
Do you recommend IP chemotherapy (as in an IV/IP regiment) for patients who have undergone an optimal primary cytoreductive surgery for advanced ovarian cancer?
1 physician has voted
Join Mednetto vote and see how they answered.